Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Ultra-clean biomedical nanofiber production now available from Nanoscience Instruments

Aseptic bioprocesses and sterile medical devices can now utilize electrospinning with the introduction of the new Fluidnatek electrospinning systems


News provided by

Nanoscience Instruments

Dec 16, 2021, 16:25 ET

Share this article

Share toX

Share this article

Share toX

Fluidnatek LE-50 ProSterile Electrospinning System
Fluidnatek LE-50 ProSterile Electrospinning System

PHOENIX, Dec. 16, 2021 /PRNewswire-PRWeb/ -- Nanoscience Instruments introduces the new biomedical Fluidnatek electrospinning systems into the US Market. Designed and built by Fluidnatek in Valencia, Spain, the new systems overcome the lack of features from commercial electrospinning equipment. The new additions deliver reproducible and scalable results, and maintain the level of sterility required for electrospinning processes in biomedical applications that fall under ISO-5, cGMP, and ISO-13485 standards.

The Fluidnatek LE-50 ProSterile and LE-100 Bio are the only electrospinning and electrospraying systems on the market that are designed specifically for a sterile process from start to finish. With these systems, you can meet FDA, cGMP, and/or ISO-13485 standards with ease, as well as carefully control processing parameters for perfect nanofibers, every time.

“The Fluidnatek systems for biomedical applications have elevated the electrospinning technique into a new era of ultra-clean medical device processing. They are meticulously designed to maintain an exceptional standard of sterility.” - Francisco J. Chaparro, PhD, Application Scientist

Post this

Nanoscience Instruments Application scientist Francisco J. Chaparro, PhD, has worked extensively with electrospinning systems, from home-built units, to premium, industrial grade systems. Dr. Chaparro explains, "The new Fluidnatek systems for biomedical applications have elevated the electrospinning technique into a new era of ultra-clean medical device processing. Meticulously designed with a comprehensive list of new features such as HEPA filtration, stainless steel interior and exterior, and a chamber sterilization system, the LE-50 ProSterile and LE-100 Bio maintain an exceptional standard of sterility and cleanliness."

With welded stainless steel interiors and exteriors with no crevices or gaps, and a vacuum chamber, these systems can maintain ISO-5 (Class 100) conditions at all times. In addition, the vacuum chamber is designed to remove traces of solvents, which eliminates the need for post process sterilization, and enables packaging of final products under sterile conditions inside the chamber. "Each new feature of the Fluidnatek systems for biomedical applications was thoughtfully chosen to ensure a fully aseptic processing environment, while maintaining a fast and easy workflow. No other electrospinning system allows a user to fabricate a medical product from start to finish inside a sterile chamber, but it is now possible with these systems," explains Matthew Dixon, PhD, Business Unit Manager.

These new features also benefit traditional electrospinning applications for regulated biomedical purposes:

  • System configurations that support embedding or encapsulating drugs to coat stents for controlled drug delivery
  • Highly reproducible nanofiber fabrication due to integrated Environmental Control, which gives users precision control over temperature, relative humidity, and air flow settings
  • Compliance with ASTM F3510-21 guidelines which mandate proper environmental controls during development of tissue engineering medical products

In addition to the systems announced above, additional configurations for making long tubular structures are available. The LE-100 biotubing allows users to fabricate tubular tissue structures and coat stents with ease. A new video highlights how the LE-100 can be configured to support the development of electrospun samples for a wide variety of applications, including stent coating, tissue grafts and scaffolds, and many more. Find more information about the LE-100 electrospinning system.

About Nanoscience Instruments

Nanoscience Instruments is a trusted supplier of the most innovative and highest quality analytical solutions to academia and industry. We specialize in microscopy and surface science instrumentation to help scientists and engineers solve complex problems leading to breakthrough innovations. Nanoscience Instruments offers a wide range of instrumentation and analytical services including scanning electron microscopes, electrospinning equipment, quartz crystal microbalances with dissipation, optical and force tensiometers, nanoparticle generators, cathodoluminescence detectors, sample preparation for SEM and TEM, and TEM accessories such as cryoEM sample preparation, in-situ sample holders, and hybrid pixel detectors. The full portfolio is available on the Nanoscience Instruments website: https://www.nanoscience.com/products/

Media Contact

Isabella Germinario, Nanoscience Instruments, 480-758-5412, [email protected]

SOURCE Nanoscience Instruments

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.